Boxer Capital’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Boxer Capital’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,500,000	Closed	-$16.7M	–	76
2023 Q3	$16.7M	Hold	2,500,000	–	–	0.89%	35
2023 Q2	$22.6M	Hold	2,500,000	–	–	1.05%	35
2023 Q1	$18.2M	Hold	2,500,000	–	–	0.89%	35
2022 Q4	$18.2M	Hold	2,500,000	–	–	0.96%	33
2022 Q3	$19.3M	Hold	2,500,000	–	–	1.09%	33
2022 Q2	$17M	Hold	2,500,000	–	–	1.08%	32
2022 Q1	$19.9M	Hold	2,500,000	–	–	1.02%	31
2021 Q4	$14M	Hold	2,500,000	–	–	0.54%	41
2021 Q3	$19.2M	Hold	2,500,000	–	–	0.67%	43
2021 Q2	$25.7M	Buy	2,500,000 +1,000,000	+67%	+$10.2M	0.91%	31
2021 Q1	$15.8M	Hold	1,500,000	–	–	0.53%	51
2020 Q4	$20.9M	Hold	1,500,000	–	–	0.67%	43
2020 Q3	$21.6M	Buy	+1,500,000	New	+$20.5M	0.75%	36

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Boxer Capital's PNT Position: Q4 2023 in Review

Boxer Capital sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 2,500,000 shares — an estimated $16.7M sold.

Boxer Capital first reported a position in PNT in Q3 2020 and held it in 13 quarters. The position peaked at $25.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Boxer Capital reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Boxer Capital sold 2,500,000 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $16.7M.
Boxer Capital first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 13 quarters.
Boxer Capital's POINT Biopharma Global Inc. Common Stock position peaked at $25.7M in Q2 2021.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Boxer Capital's 13F filing for Q4 2023, filed 14 Feb 2024.